![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Meagher E.A.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.26, Iss.13, 2003-01, pp. : 913-924
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?
By Yuan Yuhong Hunt Richard H.
Inflammopharmacology, Vol. 11, Iss. 4-6, 2003-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cyclo-Oxygenase-2 Inhibitors and the Kidney: A Case for Caution
Drug Safety, Vol. 25, Iss. 3, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selective Cyclo-Oxygenase-2 Inhibitors and Myocardial Infarction: How Strong is the Link?
By Howes L.G.
Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. :